5-Aminolevulinic acid photodynamic therapy versus minocycline for moderate-to-severe rosacea: A single-center, randomized, evaluator-blind controlled study
Journal of the American Academy of Dermatology · 2023-10 · 89 (4) · 711-718
DOI: 10.1016/j.jaad.2023.06.027 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Academy of Dermatology, 2023-10. Verfasst von Jin Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Photochemotherapy, Rosacea. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Shanghai City Science and Technology Commission, Shanghai Shenkang Hospital Development Center, Science and Technology Innovation Plan Of Shanghai Science and Technology Commission.
Abstract (Originalsprache)
BACKGROUND: 5-Aminolevulinic acid photodynamic therapy (ALA-PDT) showed potential to treat rosacea according to recent studies; however, a lack of clinical evidence and unclear adverse effects limit its use. OBJECTIVE: To compare the effect of ALA-PDT vs minocycline on rosacea. METHODS: In this single-center, randomized, evaluator-blind, controlled study, patients with moderate-to-severe rosacea were allocated to receive 3 to 5 sessions of ALA-PDT or 8 weeks of 100 mg daily minocycline treatment, followed by a 24-week follow-up. RESULTS: Of all the 44 randomized patients, 41 received complete treatment (ALA-PDT: 20 and minocycline: 21 patients). At the end of treatment, ALA-PDT showed noninferior improvement of papulopustular lesions and Rosacea-specific Quality of Life compared with minocycline (median reduction of lesion count: 19 vs 22, median change of Rosacea-specific Quality of Life score: 0.48 vs 0.53). The Clinician's Erythema Assessment success of ALA-PDT was lower than that of minocycline's (35% vs 67%). Demodex density and relapse rate were comparable in both groups. Erythema, mild pain, and exudation were the most common adverse reactions of ALA-PDT. LIMITATIONS: Limited sample size restricted us from drawing further conclusions. CONCLUSION: As minocycline does, ALA-PDT can improve rosacea mainly in papulopustular lesions and patients' quality of life, indicating a new option for rosacea.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, China.
- Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, China. Electronic address: zengqingyu2011@tongji.edu.cn.
- Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, China. Electronic address: zhangll363@126.com.
- Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, China. Electronic address: wangxiuli_1400023@tongji.edu.cn.
Förderung
- Shanghai City Science and Technology Commission
- Shanghai Shenkang Hospital Development Center
- Science and Technology Innovation Plan Of Shanghai Science and Technology Commission
- National Natural Science Foundation of China
Zitieren
APA
Yang, J., Liu, X., Cao, Y., Wang, P., Zhang, H., Chen, Q., Yang, Y., Zeng, Q., Zhang, L., & Wang, X. (2023). 5-Aminolevulinic acid photodynamic therapy versus minocycline for moderate-to-severe rosacea: A single-center, randomized, evaluator-blind controlled study. Journal of the American Academy of Dermatology, 89(4), 711-718. https://doi.org/10.1016/j.jaad.2023.06.027
Vancouver
Yang J, Liu X, Cao Y, Wang P, Zhang H, Chen Q, et al. 5-Aminolevulinic acid photodynamic therapy versus minocycline for moderate-to-severe rosacea: A single-center, randomized, evaluator-blind controlled study. Journal of the American Academy of Dermatology. 2023;89(4):711-718. doi:10.1016/j.jaad.2023.06.027
BibTeX
@article{Yang2023,
author = {Yang, Jin and Liu, Xiaojing and Cao, Yajing and Wang, Peiru and Zhang, Haiyan and Chen, Qi and Yang, Yutong and Zeng, Qingyu and Zhang, Linglin and Wang, Xiuli},
title = {5-Aminolevulinic acid photodynamic therapy versus minocycline for moderate-to-severe rosacea: A single-center, randomized, evaluator-blind controlled study},
journal = {Journal of the American Academy of Dermatology},
year = {2023},
volume = {89},
number = {4},
pages = {711--718},
doi = {10.1016/j.jaad.2023.06.027}
}
EUVIMED